Agios Pharmaceuticals, Inc. (AGIO) has a MoatMap StockRank of 15/100 based on Quality (32/100), Value (39/100), and Momentum (33/100) factor scores. The current signal is STRONG SELL. Agios Pharmaceuticals, a US healthcare (biotech) company, operates in a sector not directly linked to the identified macro themes. Biotech companies are high-risk, high-reward and typically do not fit the 'quality compounder' profile until late-stage commercialization with proven drugs, let alone an 'unpriced asymmetric macro opportunity'.